Answers are grounded in this paper and cite their sources.
We review clinical instances in which A1C should not be used and reflect on the use of other glucose metrics that can be used, in substitution of or in combination with A1C and SMBG, to tailor an individualized approach that will result in better outcomes and patient empowerment.
No takes yet. Share an insight, caveat, or question.
Wright et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: